Quincy (Mass.) Medical Center has been tapped to conduct a new clinical trial that would assess the efficacy of a GI device aimed at detecting more abnormalities during colonoscopy, according to a Boston Globe news report.
The Third Eye device enables GI physicians to view a 360-degree image of patients' colons, which reduces the risk of missing colorectal polyps. The device, which is FDA approved, is contained within a traditional colonoscopy but allows physicians to view up to 25 percent more colon abnormalities than a routine colonoscopy, according to the news report.
Read the news report about use of the Third Eye device at Quincy Medical Center.
Read other coverage about colonoscopy:
- Detection of Premalignant Colon Polyps Stable Throughout Workday Under Certain Conditions
- Position Changes During Colonoscope Withdrawal Can Increase Adenoma Detection Rate
- Study: Polypectomy Rate Can Be Used as Quality Measure
The Third Eye device enables GI physicians to view a 360-degree image of patients' colons, which reduces the risk of missing colorectal polyps. The device, which is FDA approved, is contained within a traditional colonoscopy but allows physicians to view up to 25 percent more colon abnormalities than a routine colonoscopy, according to the news report.
Read the news report about use of the Third Eye device at Quincy Medical Center.
Read other coverage about colonoscopy:
- Detection of Premalignant Colon Polyps Stable Throughout Workday Under Certain Conditions
- Position Changes During Colonoscope Withdrawal Can Increase Adenoma Detection Rate
- Study: Polypectomy Rate Can Be Used as Quality Measure